Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barrio

Showing results (361-370 of 371) with videos related to

Pageof 38
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 17, 2017
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month TrialGary W Small, Prabha Siddarth, Zhaoping Li, et al.
Neurobiology of Aging|November 14, 2008
Plaque and tangle imaging and cognition in normal aging and Alzheimer's diseaseMeredith N Braskie, Andrea D Klunder, Kiralee M Hayashi, et al.
Science Translational Medicine|November 16, 2018
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinomaClaudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, et al.
Brain Pathology (Zurich, Switzerland)|September 4, 2009
PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker diseaseVladimir Kepe, Bernardino Ghetti, Martin R Farlow, et al.
Neuroscience Letters|November 25, 2010
Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutationJohn M Ringman, Karen H Gylys, Luis D Medina, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 12, 2013
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal lossRobert M Cohen, Kavon Rezai-Zadeh, Tara M Weitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 11, 2007
The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalitiesI Rica, C Luzuriaga, G Pérez de Nanclares, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2000
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's diseaseG W Small, L M Ercoli, D H Silverman, et al.
JAMA Dermatology|June 16, 2021
Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE SyndromeColleen H Cotton, Jusleen Ahluwalia, Daniel M Balkin, et al.
Diabetologia|July 2, 2008
Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countriesT Danne, T Battelino, P Jarosz-Chobot, et al.
Pageof 38

Showing results (361-370 of 371) with videos related to

Sort By:
Pageof 38
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 17, 2017
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month TrialGary W Small, Prabha Siddarth, Zhaoping Li, et al.
Neurobiology of Aging|November 14, 2008
Plaque and tangle imaging and cognition in normal aging and Alzheimer's diseaseMeredith N Braskie, Andrea D Klunder, Kiralee M Hayashi, et al.
Science Translational Medicine|November 16, 2018
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinomaClaudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, et al.
Brain Pathology (Zurich, Switzerland)|September 4, 2009
PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker diseaseVladimir Kepe, Bernardino Ghetti, Martin R Farlow, et al.
Neuroscience Letters|November 25, 2010
Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutationJohn M Ringman, Karen H Gylys, Luis D Medina, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 12, 2013
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal lossRobert M Cohen, Kavon Rezai-Zadeh, Tara M Weitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 11, 2007
The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalitiesI Rica, C Luzuriaga, G Pérez de Nanclares, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2000
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's diseaseG W Small, L M Ercoli, D H Silverman, et al.
JAMA Dermatology|June 16, 2021
Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE SyndromeColleen H Cotton, Jusleen Ahluwalia, Daniel M Balkin, et al.
Diabetologia|July 2, 2008
Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countriesT Danne, T Battelino, P Jarosz-Chobot, et al.
Pageof 38